Healthcare Equipment and Supplies
Company Overview of Biodesix, Inc.
Biodesix, Inc., a molecular diagnostic company, discovers, develops, and commercializes cancer tests that help patients and their doctors to make informed decisions about the treatment based on a patient’s unique molecular profile. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; VeriStrat, a serum proteomic test that provides physicians with prognostic and predictive information; and an epidermal growth factor receptor mutation status study in the non-small cell lung cancer. The company also operates a specialty laboratory to provide reflex testing to minimize turnaround time between genomic and proteomic testing. The company was form...
2970 Wilderness Place
Boulder, CO 80301
Founded in 2005
Key Executives for Biodesix, Inc.
Chief Executive Officer and Director
Vice President of Product Development and Operations
Compensation as of Fiscal Year 2016.
Biodesix, Inc. Key Developments
Biodesix, Inc. Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-11-2016 11:10 AM
Jan 19 16
Biodesix, Inc. Presents at The Leerink Partners 5th Annual Global Healthcare Conference, Feb-11-2016 11:10 AM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: David W. Brunel, Chief Executive Officer and Director.
Biodesix, Inc. Presents at JMP Securities Life Sciences Conference, Jun-23-2015 02:30 PM
May 7 15
Biodesix, Inc. Presents at JMP Securities Life Sciences Conference, Jun-23-2015 02:30 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States.
Biodesix, Inc. Announces Executive Appointments
Feb 18 15
Biodesix, Inc. announced that Wendy Blosser is joining the company, and will serve as Vice President, Sales driving the sales of Biodesix expanding portfolio of blood-based tests in oncology. In addition, two other leaders have stepped into newly created roles: Jasmine Gruia-Gray, PhD. has assumed management of all marketing activities as the Vice President of Marketing and Robin Cowie has been promoted to the newly created role of Vice President, Reimbursement and Health Care Economics. Ms. Blosser is an oncology industry veteran who most recently held the position of US Vice President of Sales at Integrated Oncology. Ms. Cowie joined Biodesix in 2011 as the company's first director of reimbursement. Ms. Cowie's previous experience in reimbursement, payer and government affairs came during several years at Precision Therapeutics, Inc. Dr. Gruia-Gray joined Biodesix in 2014. Previously, she held the position of Vice President, Global Marketing at Affymetrix, Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 13, 2016